Literature DB >> 24491822

Diagnosis and classification of central nervous system vasculitis.

Rula A Hajj-Ali1, Leonard H Calabrese2.   

Abstract

Central nervous system vasculitis is one of the foremost diagnostic challenges in rheumatology. It results in inflammation and destruction of the vasculature within the CNS. When vasculitis is confined to brain, meninges or spinal cord, it is referred to as primary angiitis of the CNS. Secondary CNS vasculitis occurs in the setting of a systemic vasculitis, auto-inflammatory or infectious disease. Prompt and accurate diagnosis of CNS vasculitis is essential to prevent irreversible brain damage, and to secure precise treatment decisions. Progressive debilitating and unexplained neurological deficits, associated with abnormal cerebrospinal fluid is the typical picture of the disease. Biopsy of the brain remains the gold standard diagnostic test. The differential diagnosis of CNS vasculitis is highly diverse with a broad array of mimics at the clinical, radiographic and angiographic levels.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CNS vasculitis; Primary angiitis of the central nervous system

Mesh:

Year:  2014        PMID: 24491822     DOI: 10.1016/j.jaut.2014.01.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  31 in total

Review 1.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

2.  Cognitive decline in an older physician.

Authors:  Gregory S Day; Simon Carette; David F Tang-Wai
Journal:  CMAJ       Date:  2015-03-30       Impact factor: 8.262

3.  A rare case of ANCA-associated cerebral vasculitis.

Authors:  Maria Grazia Massaro; Rossella Cianci; Emilio Lozupone; Pietro Trombatore; Giovanni Gambassi
Journal:  Intern Emerg Med       Date:  2020-09-13       Impact factor: 3.397

4.  Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.

Authors:  Olga Vera-Lastra; Jesús Sepúlveda-Delgado; María del Pilar Cruz-Domínguez; Gabriela Medina; Moisés Casarrubias-Ramírez; Luis E Molina-Carrión; Luis F Pineda-Galindo; Arturo Olvera-Acevedo; Claudia Hernández-Gonzalez; Luis J Jara
Journal:  Clin Rheumatol       Date:  2014-11-27       Impact factor: 2.980

5.  Case Report: Reversible Cerebral Vasoconstriction Syndrome in Cerebral Malaria.

Authors:  Kei Yamamoto; Yasuyuki Kato; Koh Shinohara; Satoshi Kutsuna; Nozomi Takeshita; Kayoko Hayakawa; Moritoshi Iwagami; Shigeyuki Kano; Shu Watanabe; Norio Ohmagari
Journal:  Am J Trop Med Hyg       Date:  2017-12-14       Impact factor: 2.345

6.  Pseudo-insular glioma syndrome: illustrative cases.

Authors:  Alexander F Haddad; Jacob S Young; Ramin A Morshed; S Andrew Josephson; Soonmee Cha; Mitchel S Berger
Journal:  J Neurosurg Case Lessons       Date:  2021-12-27

7.  Comparison of High-Resolution MR Imaging and Digital Subtraction Angiography for the Characterization and Diagnosis of Intracranial Artery Disease.

Authors:  N J Lee; M S Chung; S C Jung; H S Kim; C-G Choi; S J Kim; D H Lee; D C Suh; S U Kwon; D-W Kang; J S Kim
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-22       Impact factor: 3.825

Review 8.  The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.

Authors:  Marc-Etienne Parent; Maxime Richer; Patrick Liang
Journal:  Clin Rheumatol       Date:  2018-05-09       Impact factor: 2.980

Review 9.  Primary CNS lymphoma initially diagnosed as vasculitis.

Authors:  Lauren Feldman; Yuebing Li; Daniel Ontaneda
Journal:  Neurol Clin Pract       Date:  2020-02

10.  The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis.

Authors:  Judith Leyens; Tim Th A Bender; Martin Mücke; Christiane Stieber; Dmitrij Kravchenko; Christian Dernbach; Matthias F Seidel
Journal:  Orphanet J Rare Dis       Date:  2021-07-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.